𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy

✍ Scribed by Brown, Charlotte A. ;Lanning, Robert W. ;McKinney, Kimberly Q. ;Salvino, Ann R. ;Cherniske, Elizabeth ;Crowe, Carol A. ;Darras, Basil T. ;Gominak, Stasha ;Greenberg, Cheryl R. ;Grosmann, Carla ;Heydemann, Peter ;Mendell, Jerry R. ;Pober, Barbara R. ;Sasaki, Takeshi ;Shapiro, Frederick ;Simpson, David A. ;Suchowersky, Oksana ;Edward Spence, J.


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
232 KB
Volume
102
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Six novel mutations in the emerin gene c
✍ Karin Wulff; Julia E. Parrish; Falko H. Herrmann; Manfred Wehnert πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 150 KB πŸ‘ 2 views

## Communicated by Jiirgen Horst Mutations in the emerin gene, also referred to as the STA-or EMD-gene, have been found to be the cause of X-linked Emery-Dreifuss muscular dystrophy (EMD). For the present study an optimized set of primers was designed to amplify and sequence each of the six emerin

Identification of recurrent and novel mu
✍ Ana Cenarro; Henrik K. Jensen; Elena Casao; Fernando Civeira; JosΓ© GonzΓ‘lez-Boni πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 46 KB πŸ‘ 2 views

We used the single strand conformation polymorphism (SSCP) method to investigate 13 apparently unrelated Spanish patients with familial hypercholesterolemia (FH) for mutations in the promoter region and the 18 exons and their flanking intron sequences of the low density lipoprotein (LDL) receptor ge

Clinical, pathological, and genetic feat
✍ Hisaomi Kawai; Masashi Akaike; Makoto Kunishige; Toshio Inui; Katsuhito Adachi; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 469 KB πŸ‘ 2 views

We report on the clinical, pathological, and genetic features of 7 patients with limb-girdle muscular dystrophy type 2A (LGMD2A) from three Japanese families. The mean age of onset was 9.7 Β± 3.1 years (mean Β± SD), and loss of ambulance occurred at 38.5 Β± 2.1 years. Muscle atrophy was predominant in